Experts warn of a critical shortage of obstetric medicines in Australia, jeopardizing the health of pregnant women. Key medications for managing high blood pressure and preventing complications like pre-eclampsia are in short supply due to manufacturing disruptions and the lack of incentive for pharmaceutical companies to produce older, off-patent drugs. Calls for government action include establishing a publicly funded body to manage the registration and supply of essential medications for pregnancy. Additionally, the underrepresentation of pregnant women in clinical trials limits the availability of new treatments, leaving healthcare providers reliant on outdated drugs. The situation is particularly dire in rural areas, where access to these medications can be even more restricted. Experts stress that urgent reforms are necessary to ensure continuous access to safe and effective treatments for pregnant women.